Q&A with Tran­sCel­er­ate’s new CEO Jan­ice Chang: Bring­ing the tri­al in­fra­struc­ture to pa­tients

Tran­sCel­er­ate Bio­phar­ma is unique in the non­prof­it space be­cause it brings to­geth­er more than 20 top phar­ma com­peti­tors and al­lows them to col­lab­o­rate, rather than com­pete, on com­mon R&D pain points.

Help­ing to build this col­lab­o­ra­tive en­vi­ron­ment is Tran­sCel­er­ate’s new CEO Jan­ice Chang, who moved in­to her new role in Jan­u­ary af­ter serv­ing as COO for more than a decade.

Chang sat down with End­points News for an in-per­son in­ter­view at the DIA con­fer­ence in Boston on Wednes­day. Be­low is a light­ly edit­ed ver­sion of that con­ver­sa­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER